Mars J, Culjkovic-Kraljacic B, Borden K
Nucleus. 2024; 15(1):2360196.
PMID: 38880976
PMC: 11185188.
DOI: 10.1080/19491034.2024.2360196.
Borden K
Bioessays. 2023; 46(1):e2300145.
PMID: 37926700
PMC: 11021180.
DOI: 10.1002/bies.202300145.
Ghram M, Morris G, Culjkovic-Kraljacic B, Mars J, Gendron P, Skrabanek L
EMBO J. 2023; 42(7):e110496.
PMID: 36843541
PMC: 10068332.
DOI: 10.15252/embj.2021110496.
Mars J, Ghram M, Culjkovic-Kraljacic B, Borden K
Cancers (Basel). 2021; 13(24).
PMID: 34944805
PMC: 8699206.
DOI: 10.3390/cancers13246185.
Kachaev Z, Ivashchenko S, Kozlov E, Lebedeva L, Shidlovskii Y
Cells. 2021; 10(11).
PMID: 34831461
PMC: 8623629.
DOI: 10.3390/cells10113239.
Control of the eIF4E activity: structural insights and pharmacological implications.
Romagnoli A, DAgostino M, Ardiccioni C, Maracci C, Motta S, La Teana A
Cell Mol Life Sci. 2021; 78(21-22):6869-6885.
PMID: 34541613
PMC: 8558276.
DOI: 10.1007/s00018-021-03938-z.
Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential.
Moyano P, Nemec V, Paruch K
Int J Mol Sci. 2020; 21(20).
PMID: 33066143
PMC: 7593917.
DOI: 10.3390/ijms21207549.
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α.
Maida I, Zanna P, Guida S, Ferretta A, Cocco T, Palese L
J Transl Med. 2019; 17(1):20.
PMID: 30634982
PMC: 6329103.
DOI: 10.1186/s12967-019-1772-z.
Reversible RNA Modification N-methyladenosine (mA) in mRNA and tRNA.
Zhang C, Jia G
Genomics Proteomics Bioinformatics. 2018; 16(3):155-161.
PMID: 29908293
PMC: 6076376.
DOI: 10.1016/j.gpb.2018.03.003.
Human herpesvirus-encoded kinase induces B cell lymphomas in vivo.
Anders P, Montgomery N, Montgomery S, Bhatt A, Dittmer D, Damania B
J Clin Invest. 2018; 128(6):2519-2534.
PMID: 29733294
PMC: 5983348.
DOI: 10.1172/JCI97053.
Deletion of eIF2β lysine stretches creates a dominant negative that affects the translation and proliferation in human cell line: A tool for arresting the cell growth.
Salton G, Laurino C, Mega N, Delgado-Canedo A, Setterblad N, Carmagnat M
Cancer Biol Ther. 2017; 18(8):560-570.
PMID: 28692326
PMC: 5653189.
DOI: 10.1080/15384047.2017.1345383.
The eukaryotic translation initiation factor eIF4E wears a "cap" for many occasions.
Borden K
Translation (Austin). 2017; 4(2):e1220899.
PMID: 28090419
PMC: 5173310.
DOI: 10.1080/21690731.2016.1220899.
mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
Josse L, Xie J, Proud C, Smales C
Biochem J. 2016; 473(24):4651-4664.
PMID: 27760840
PMC: 5147049.
DOI: 10.1042/BCJ20160845.
Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.
Volpon L, Culjkovic-Kraljacic B, Osborne M, Ramteke A, Sun Q, Niesman A
Proc Natl Acad Sci U S A. 2016; 113(19):5263-8.
PMID: 27114554
PMC: 4868427.
DOI: 10.1073/pnas.1524291113.
Identification of a novel RNA giant nuclear body in cancer cells.
Zhou H, Zhang J, Gu Y, Gan X, Gan Y, Zheng W
Oncotarget. 2015; 7(4):4724-34.
PMID: 26678034
PMC: 4826238.
DOI: 10.18632/oncotarget.6619.
The Eukaryotic Translation Initiation Factor 4E (eIF4E) as a Therapeutic Target for Cancer.
Karaki S, Andrieu C, Ziouziou H, Rocchi P
Adv Protein Chem Struct Biol. 2015; 101:1-26.
PMID: 26572974
PMC: 7185574.
DOI: 10.1016/bs.apcsb.2015.09.001.
Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches.
Martinez A, Sese M, Hernandez Losa J, Robichaud N, Sonenberg N, Aasen T
PLoS One. 2015; 10(4):e0123352.
PMID: 25923732
PMC: 4414544.
DOI: 10.1371/journal.pone.0123352.
Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency.
Kasippillai T, MacArthur D, Kirby A, Thomas B, Lambalk C, Daly M
J Clin Endocrinol Metab. 2013; 98(9):E1534-9.
PMID: 23902945
PMC: 5393467.
DOI: 10.1210/jc.2013-1102.
The oncogene eIF4E: using biochemical insights to target cancer.
Carroll M, Borden K
J Interferon Cytokine Res. 2013; 33(5):227-38.
PMID: 23472659
PMC: 3653383.
DOI: 10.1089/jir.2012.0142.
Crystal structure of a minimal eIF4E-Cup complex reveals a general mechanism of eIF4E regulation in translational repression.
Kinkelin K, Veith K, Grunwald M, Bono F
RNA. 2012; 18(9):1624-34.
PMID: 22832024
PMC: 3425778.
DOI: 10.1261/rna.033639.112.